Clinical Trials

New Search
Title   Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
Disease/Condition   Brain Cancer,Metastatic Cancer
Eligibility Criteria   Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   William Bodner, MD
Contact Name   Alyssa Asaro
Phone   (718) 920-7750
Contact Email
IRB/Protocol Number   IRB# 2015-5530
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No